Author

Frank H. J. Wolfhagen

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL
COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Frank H. J. Wolfhagen  et al.

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL
CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Frank H. J. Wolfhagen  et al.

SURVEILLANCE WITH SALVAGE SURGERY AS AN ALTERNATIVE TO COMPLETION SURGERY AFTER LOCAL EXCISION OF A T1 CRC WITH HISTOLOGICAL RISK FACTORS
SURVEILLANCE WITH SALVAGE SURGERY AS AN ALTERNATIVE TO COMPLETION SURGERY AFTER LOCAL EXCISION OF A T1 CRC WITH HISTOLOGICAL RISK FACTORS

Frank H. J. Wolfhagen  et al.

A STRATEGY OF LOCAL FULL-THICKNESS SCAR RESECTION FOLLOWING R1/RX EXCISED T1 COLORECTAL CANCER SHOWS SIMILAR METASTASIS-FREE AND OVERALL SURVIVAL AS COMPARED TO COMPLETION SURGERY
A STRATEGY OF LOCAL FULL-THICKNESS SCAR RESECTION FOLLOWING R1/RX EXCISED T1 COLORECTAL CANCER SHOWS SIMILAR METASTASIS-FREE AND OVERALL SURVIVAL AS COMPARED TO COMPLETION SURGERY

Frank H. J. Wolfhagen  et al.

Item 1 - 4 / 4
1